Comments
Loading...

Seres Therapeutics Stock Guidance

MCRBNASDAQ
Logo brought to you by Benzinga Data
$0.7467
0.008801.19%
At close: -
$0.7380
-0.00870-1.17%
After Hours: 7:51 PM EDT
Q4 2024 Earnings were released on Thu Mar 13th, before the market open
The most recent conference call was at 8:30 AM, 5 days ago Click to view past webcast

Seres Therapeutics Stock Guidance | NASDAQ:MCRB | Benzinga

Seres Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
Seres Therapeutics Inc (MCRB) does not provide guidance data

FAQ

Q

What is the most recent guidance for Seres Therapeutics (MCRB)?

A

There have been no specific sales or earnings guidance reported for Seres Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch